treating adults treating kids Stimulant shortage

“The DEA’s Manufactured Crisis”

Reading now: 889
www.additudemag.com

The following is a personal essay reflecting the opinions of the author.It began with an Adderall shortage in 2022. Today, prescriptions for many stimulant medications used as the first-line treatment of ADHD are consistently and frustratingly difficult to fill.

So it’s unsurprising that ADHD features prominently in the majority of public comments submitted to the Federal Trade Commission (FTC) by stakeholders impacted by long-term medication shortages involved in the treatment of many conditions, including cancer.

ADHD patients demand attention on their suffering.But, by inviting public testimony on the stimulant shortage and pharmaceutical practices, I believe the FTC is only trying to find cover for the Drug Enforcement Administration (DEA).

Read more on additudemag.com
The website mental.guide is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles

additudemag.com
53%
479
We Demand Attention on How Medication Adjustments During the Monthly Menstrual Cycle and Menopause Could Improve Treatment Outcomes for Women
A small study suggests that menstruating people with ADHD may achieve more effective and consistent symptom control by increasing the dosage of their prescribed stimulant medication in the luteal phase, when estrogen levels hit their lowest point.There is a dearth of research examining the changes in ADHD symptoms and medication efficacy during all phases of the menstrual cycle, and during other times of hormonal change.However, one 2023 study published in Front Psychiatry found that increasing a patient’s dosage of stimulant medication during the week prior to menstruation can significantly improve cognitive and emotional symptoms of ADHD during this notoriously difficult phase in the menstrual cycle.1 The study was the first of its kind to examine the impact of adjusting stimulant medication dosages during the menstrual cycle for women with ADHD and co-occurring depression and premenstrual dysphoric disorder (PMDD) – a severe form of PMS.Prior to the study, these women experienced “diminished response to amphetamines in the late luteal phase” and an “exacerbation of their ADHD and depressive symptoms in the premenstrual week” that was not helped by their regular ADHD medication. This experience was echoed in ADDitude’s 2023 survey of nearly 2,000 women with ADHD, two-thirds of whom said they experienced intense symptoms of premenstrual syndrome (PMS) or PMDD, beginning, on average, at age 14 and lasting for up to 40 years.
DMCA